Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
06/1999
06/17/1999DE19754796A1 Neue, von Azacycloalkanen abgeleitete Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung New-derived azacycloalkanes urethanes, their thio and Dithioanaloga, salts thereof, pharmaceutical compositions containing them and their use, and processes for their preparation
06/17/1999CA2313194A1 Method for producing salts of cyclic amidines
06/17/1999CA2312423A1 Inhibition of membrane-associated viral replication
06/17/1999CA2309388A1 New urethanes derived from azacycloalkanes, the thio and dithio analogues thereof, the salts thereof, pharmaceutical compositions containing these compounds and their use as well as processes for preparing them
06/16/1999EP0922031A1 A process for the preparation of dihydropyridines
06/16/1999EP0922030A1 Arylsulfonylamino hydroxamic acid derivatives
06/16/1999EP0922029A1 Ether muscarinic antagonists
06/16/1999CN1219534A Preparation method for polymerized hindered amine light stabilizer monomer
06/16/1999CN1043609C Process for preparing pharmaceutical composition containing benzothiazole compounds
06/15/1999US5912351 Anhydrous 1,4-Dihydropyridines and salts thereof
06/15/1999US5912350 Certain aminomethyl biphenyl, aminomethyl phenyl pyridine and aminomethyl phenyl pyrimidine derivatives; novel dopamine receptor subtype selective ligands
06/15/1999US5912242 N-(4-substituted-benzyl)-2-aminolactam derivatives
06/15/1999CA2154704C Automatic dishwashing compositions comprising quaternary substituted bleach activators
06/15/1999CA2087032C Diphenylmethyl piperazine derivatives
06/10/1999WO1999028456A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening
06/10/1999WO1999028359A1 Preparation for prevention and healing of inflammation affections
06/10/1999DE19754322A1 Verfahren zur Herstellung von Salzen cyclischer Amidine A process for the preparation of salts of cyclic amidines
06/10/1999CA2310541A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening
06/09/1999EP0920306A2 Chemokine receptor antagonists and methods of use therefor
06/09/1999CN1219172A Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
06/09/1999CN1219170A Substituted 1,2,3,4-tetrahydronaphthalene derivatives
06/09/1999CN1219167A Preparation of Lactams from aliphatic alpha, omega-dinitriles
06/08/1999US5910593 Highly selective process for the preparation of enantiomerically pure phenylsubstituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives
06/08/1999US5910591 Reacting 4-hydroxy-2,2,6,6,-tetramethylpiperidine with formaldehyde, paraformaldehyde or trioxane; neutralizing with base; separating, crystallizing and filtering; reduction of water content of crystals; circulation
06/08/1999US5910232 Method for inhibiting polymer formation in styrene processing
06/08/1999CA2089972C Sulfonamidocarboxamides
06/08/1999CA1340588C Amino acid derivatives
06/03/1999WO1999026927A2 Metabotropic glutamate receptor antagonists for treating central nervous system diseases
06/03/1999WO1999026924A1 Substituted oximes as neurokinin antagonists
06/03/1999WO1999026921A1 SUBSTITUTED β-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS
06/03/1999WO1999026920A1 Substituted 3-amino-2-hydroxyphenylacetamide derivatives as enzyme inhibitors (ii)
06/03/1999WO1999026918A1 Biphenylamidine derivatives
06/03/1999WO1999026615A1 Cyclic amino acid derivatives as cell adhesion inhibitors
06/03/1999WO1999026614A1 Substituted 2-aminoacetamides and the use thereof
06/03/1999WO1999010312B1 N-alkanoylphenylalanine derivatives
06/03/1999CA2311131A1 Metabotropic glutamate receptor antagonists for treating central nervous system diseases
06/03/1999CA2310331A1 Biphenylamidine derivatives
06/03/1999CA2309341A1 Substituted .beta.-alanine derivatives as cell adhesion inhibitors
06/03/1999CA2309338A1 Cyclic amino acid derivatives as cell adhesion inhibitors
06/02/1999EP0918822A1 Copolymers of propylene with polymerizable hindered amine light stabilizers
06/02/1999EP0918792A1 Dipeptide benzamidine as a kininogenase inhibitor
06/02/1999EP0918781A1 Asymmetric synthesis catalyzed by transition metal complexes with cyclic chiral ligands
06/02/1999EP0918773A1 Process for the production of 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo 1,5-a]benzodiazepine
06/02/1999EP0918767A1 Pharmaceutical for treating of neurological and neuropsychiatric disorders
06/02/1999EP0918761A1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands
06/02/1999EP0918755A1 1-alkyl-4-benzoyl-5-hydroxypyrazole compounds and their use as herbicides
06/02/1999EP0918746A1 Immunotherapeutic agents and their use in the reduction of cytokine levels
06/02/1999EP0748310B1 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity
06/02/1999CN1218023A Transesterification process
06/01/1999US5908954 Chemical intermediate
06/01/1999US5908935 Process for the preparation of 1-Acyl-4-arylpiperidines
06/01/1999US5908934 Chemical intermediate for kinase inhibitors
06/01/1999US5908863 Geminal carboxylic acids and esters thereof pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism
06/01/1999CA2103590C Benzamide derivative
05/1999
05/27/1999WO1999025714A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
05/27/1999WO1999025689A1 Process for the preparation of acetal derivatives of 1,4-dihydropyridines
05/27/1999WO1999025688A1 Process for the preparation of 1,4-dihydropyridines and compounds used in this process
05/27/1999WO1999025687A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
05/27/1999WO1999025686A1 Cyclic amine derivatives and their use as drugs
05/27/1999WO1999025685A1 4-substituted-4-piperidine carboxamide derivatives
05/27/1999WO1999025345A1 Alpha-1a adrenergic receptor antagonists
05/27/1999CA2306460A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
05/26/1999EP0917465A1 Antimalarial and anti-babesiosis agents and pharmaceutical compositions containing same
05/26/1999EP0917464A1 Use of amines to produce drugs for preventing tumour cell proliferation
05/26/1999EP0917462A1 Cell adhesion inhibitors
05/26/1999EP0819117B1 Dimethylamine benzoate or p-anisate catalysed process for the preparation of 4-(nitrophenyl)-dihydropyridines
05/26/1999EP0746545B1 Nipecotic acid derivatives as antithrombic compounds
05/26/1999EP0686625B1 Anthranilic acid derivative
05/25/1999US5907039 Amino alcohol derivative and method for preparing the same
05/25/1999US5907038 Azepanes
05/20/1999WO1999024460A2 Dipeptide nitriles
05/20/1999WO1999024402A1 N-oxyl compounds, process for the preparation thereof, and process for inhibiting the polymerization of vinyl monomers with the same
05/20/1999WO1999024401A1 Use of alkylated iminosugars to treat multidrug resistance
05/20/1999WO1999024399A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999CA2309321A1 Use of alkylated iminosugars to treat multidrug resistance
05/20/1999CA2308359A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/19/1999EP0916667A1 Optically active 1,4-dihydropyridine derivatives and process for the preparation thereof
05/19/1999EP0915860A1 Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands
05/19/1999EP0915855A1 Novel compounds with analgesic effect
05/19/1999EP0915849A2 Process for the preparation of 3,3-disubstituted piperidines
05/19/1999CN1216979A Process for purifying sterically hindered 4-amino piperidines
05/19/1999CN1043425C Sub-salicylic amino transition metal compounding agent and it mfg. method
05/18/1999US5905077 Inhibitors of HIV protease useful for the treatment of AIDS
05/14/1999WO1999023073A1 Biphenyl derivatives as pharmaceuticals
05/14/1999WO1999023072A1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
05/14/1999WO1999023063A1 Substituted anilides
05/14/1999WO1999022717A1 Novel formulation for use in pain management
05/14/1999WO1999010338A3 Benzylidene- and cinnamylidene-anabaseines as neuronal nicotinic alpha-7 receptor agonists
05/14/1999CA2681877A1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
05/14/1999CA2309122A1 Novel formulation for use in pain management
05/14/1999CA2308151A1 Biphenyl derivatives as pharmaceuticals
05/12/1999EP0914605A1 Molecular model for vla-4 inhibitors
05/12/1999CN1216469A Peripheral circulation improvers for ophthalmic tissues containing dihydropyridines
05/11/1999CA2186263C Separation of the enantiomers of amlodipine via their diastereomeric tartrates
05/11/1999CA1340541C Analgesic carboxylic acid amide derivatives
05/06/1999WO1999021855A1 Pleuromutilin derivatives as antimicrobials
05/06/1999WO1999021854A1 Bis-quaternary ammonium derivatives as neuromuscular relaxants
05/06/1999WO1999021846A1 Cyclopentene derivatives useful as antagonists of the motilin receptor
05/06/1999WO1999021832A2 Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders
05/06/1999WO1999021823A1 Optically active intermediates for the preparation of optically active substituted oximes, hydrazones and olefins useful as neurokinin antagonists